Jan 9 (Reuters) – Biopharmaceutical company Veradermics filed for an initial public offering in the United States on Friday.
U.S. IPOs are likely to gain momentum this year if anticipated interest-rate cuts boost investor confidence and risk appetite.
Biopharmaceutical company Eikon Therapeutics also filed for a U.S. IPO earlier in the day.
Veradermics plans to list on the New York Stock Exchange under the symbol “MANE.”
Jefferies, Citigroup and Leerink Partners are the underwriters for the offering.
(Reporting by Prakhar Srivastava in Bengaluru; Editing by Shilpi Majumdar and Tasim Zahid)
Comments